Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

BRTJ Formula Finest Choice Boosted - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/BRTJ Formula Finest Choice Boosted

Approved

STANDARD

BRTJ Formula Finest Choice Boosted

Vecta Biotech🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 2bee260b3b00ee02
Company: Vecta Biotech
Type: Standard

Approval Details

Approval Id: 2bee260b3b00ee02
Drug Approval Philippines Name: BRTJ Formula Finest Choice Boosted
Product Name: BRTJ Formula Finest Choice Boosted
Registration Number: DRP-13066
Brand Name: BRTJ Formula Finest Choice Boosted
Generic Name: Ascorbic Acid + Zinc+ Colecalciferol (Vitamin D3)
Dosage Form: Film Coated Tablet
Dosage Strength: 1 g/10 mg (equivalent to 40 mg Zinc Sulphate)/1000 IU
Manufacturer: Vecta Biotech
Importer: BFS Health Corporation
Distributor: BFS Health Corporation
Issuance Date: 24 November 2022
Expiry Date: 24 November 2027
Classification: Over-the-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

2bee260b3b00ee02

Type

Standard

Back to Philippines FDA Approvals